Company: ARTL
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001640334-25-002022
Chunk: 61

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 2
Chunk 61
---
 sale transactions. Any debt or additional equity financings that we complete may contain terms that are not favorable to us or our stockholders.

Working Capital

  September 30,  December 31,    (In thousands) 2025  2024  Change Current Assets $1,827  $2,557  $(730)Current Liabilities  4,860   1,772   3,088 Working Capital $(3,033) $785  $(3,818)

Our total current assets as of September 30, 2025, were $1.8 million as compared to total current assets of $2.6 million as of December 31, 2024. The decrease in current assets was primarily due to the funding of our operating activities in excess of the cash raised in our financings completed during the current year.

Our total current liabilities as of September 30, 2025, were $4.9 million as compared to total current liabilities of $1.8 million as of December 31, 2024, the result of our deferring payment to certain vendors as a result of our cash preservation strategy.

Historical Cash Flows

The following table summarizes our cash flows for the periods indicated:

  Nine Months Ended      September 30,    (In thousands) 2025  2024  Change Cash flows used in operating activities $(5,609) $(5,783) $174 Cash flows (used in) provided by investing activities  (250)  7,269   (7,519)Cash flows provided by financing activities  5,260   55   5,205 Effect of exchange rate changes on cash  (19)  1   (20)Net change in cash and cash equivalent during period $(618) $1,542  $(2,160)

Cash Flows from Operating Activities

During the nine months ended September 30, 2025, cash used in operating activities was $5.6 million compared to $5.8 million during the nine months ended September 30, 2024. Cash used in operating activities during the nine months ended September 30, 2025, was attributed to a net loss of $8.7 million offset by decreases in operating assets and increases in liabilities of $2.2 million and non-c